These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. A derivative of myelin-associated glycoprotein in cerebrospinal fluid of normal subjects and patients with neurological disease. Yanagisawa K, Quarles RH, Johnson D, Brady RO, Whitaker JN. Ann Neurol; 1985 Oct; 18(4):464-9. PubMed ID: 2416268 [Abstract] [Full Text] [Related]
11. Terminal component of complement (C9) in the cerebrospinal fluid of patients with multiple sclerosis and neurologic controls. Rodriguez M, Wynn DR, Kimlinger TK, Katzmann JA. Neurology; 1990 May; 40(5):855-7. PubMed ID: 2330118 [Abstract] [Full Text] [Related]
12. Terminal component of complement (C9) in cerebrospinal fluid of patients with multiple sclerosis. Morgan BP, Campbell AK, Compston DA. Lancet; 1984 Aug 04; 2(8397):251-4. PubMed ID: 6146808 [Abstract] [Full Text] [Related]
13. CSF protein and cellular profiles in various stages of HIV infection related to neurological manifestations. Elovaara I, Iivanainen M, Valle SL, Suni J, Tervo T, Lähdevirta J. J Neurol Sci; 1987 May 04; 78(3):331-42. PubMed ID: 3035107 [Abstract] [Full Text] [Related]
14. Cerebrospinal fluid proteins and serum immunoglobulins. Occurrence in multiple sclerosis and other neurological diseases: comparative measurement of gamma-globulin and the IgG class. Fischer-Williams M, Roberts RC. Arch Neurol; 1971 Dec 04; 25(6):526-34. PubMed ID: 4107216 [No Abstract] [Full Text] [Related]
19. Protein profile of human perilymph: in search of markers for the diagnosis of perilymph fistula and other inner ear disease. Thalmann I, Kohut RI, Ryu J, Comegys TH, Senarita M, Thalmann R. Otolaryngol Head Neck Surg; 1994 Sep 04; 111(3 Pt 1):273-80. PubMed ID: 8084635 [Abstract] [Full Text] [Related]